
FDA removes risk evaluation and mitigation strategy (REMS) program for the antipsychotic drug Clozapine
Clozapine is an atypical antipsychotic medicine used to treat people who are severely ill with schizophrenia who remain symptomatic on other schizophrenia medicines. Clozapine is thought to work by balancing the brain’s levels of dopamine and serotonin, …